MedTrace Logo

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

NCT00780832 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2016-02-24

No results posted yet for this study

Summary

The purpose of this study is to assess the effects of caffeine reduction/elimination on urinary symptoms in women with overactive bladders and compare this therapeutic approach to anticholinergic therapy. We hope to show a reduction in symptoms with caffeine reduction and determine how effective caffeine reduction is compared to medication. If caffeine reduction is shown to be beneficial, women may be encouraged to use this strategy before resorting to medications.

Conditions

Interventions

BEHAVIORAL

Dietary Caffeine reduction

Participants are counseled about reduction of dietary caffeine, given written information and a bladder control log.

DRUG

Anticholinergic medication

Detrol LA 4mg. orally, once daily for 30 days

Sponsors & Collaborators

  • IWK Health Centre

    lead OTHER

Principal Investigators

  • Scott A Farrell, MD, FRCSC · IWK Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2012-12-31
Completion
2013-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00780832 on ClinicalTrials.gov